Rapamycin as an alternative to surgical treatment of subependymal giant cell astrocytomas in a patient with tuberous sclerosis complex
Authors:
- 1 October 2010
- journal article
- case report
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of neurosurgery. Pediatrics
- Vol. 6 (4) , 381-384
Abstract
Tuberous sclerosis complex (TSC) is associated with the potential development of benign hamartomas, including subependymal giant cell astrocytomas (SEGAs). Intracranial hypertension can be caused by SEGAs due to their propensity to block the foramen of Monro. The traditional management approach is to monitor SEGAs with periodic neuroimaging and to resect those that exhibit serial growth and/or cause clinical signs of intracranial hypertension. Recent observations suggest that rapamycin therapy may induce partial regression of SEGAs, therefore providing a potential alternative to resection. The authors present the case of an 8-year-old girl with bilateral SEGAs that led to progressive hydrocephaly and incipient signs of papilledema. Three months after initiating rapamycin therapy, the SEGAs exhibited significant reduction in size (82.6% on the left and 46.7% on the right), and the lesions remained stable 5 months later. Compared with previous case reports, similar or even greater antitumor efficacy was achieved with much lower trough levels of rapamycin (10–15 compared with 3.3–4.5 ng/ml, respectively). The authors discuss various aspects of rapamycin therapy and address unresolved issues that highlight the need for further prospective clinical trials.Keywords
This publication has 29 references indexed in Scilit:
- From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosisJournal of Intellectual Disability Research, 2009
- Tuberous sclerosisThe Lancet, 2008
- Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosisNature Medicine, 2008
- Sirolimus Therapy in Tuberous Sclerosis or Sporadic LymphangioleiomyomatosisNew England Journal of Medicine, 2008
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or LymphangioleiomyomatosisNew England Journal of Medicine, 2008
- Cognitive deficits in Tsc1+/−mice in the absence of cerebral lesions and seizuresAnnals of Neurology, 2007
- Dramatic effect of sirolimus on renal angiomyolipomas in a patient with tuberous sclerosis complexEuropean Journal of Internal Medicine, 2007
- Rapamycin causes regression of astrocytomas in tuberous sclerosis complexAnnals of Neurology, 2006
- Subependymal giant cell tumors in tuberous sclerosis complexNeurology, 2004
- Identification and characterization of the tuberous sclerosis gene on chromosome 16Cell, 1993